Premature infants may get metabolic boost from mom's breast milkSeptember 14, 2017
The breast milk of mothers with premature babies has different amounts of microRNA than that of mothers with babies born at term, which may help premature babies catch up in growth and development, according to researchers.
In a study, researchers compared the breast milk of mothers with babies born prematurely -- between 28 and 37 weeks gestation -- and at term -- after 38 weeks. They examined whether there were differences in the composition of the breast milks' microRNAs, snippets of RNA that affect gene expression and can be passed to the infant.
"We found that there are differences in these microRNA profiles, and that the majority of the altered microRNAs influence metabolism," said Molly Carney, medical student in the Penn State College of Medicine. "If those microRNAs are being transferred to the infant, that could potentially impact how the newborn processes energy and nutrients."
The researchers said the results -- recently published in Pediatric Research -- could help better match babies with donated breast milk and give insight into how to develop better infant formula.
Babies born prematurely are at risk for a host of problems, including failure to thrive and neurodevelopmental delays. They also tend to be born at a lower weight than term infants. Because of these issues, premature babies have different nutritional needs than babies born at term.
Previous research has established that the macronutrients -- fats, sugars and proteins -- in the breast milk of mothers with premature babies are customized to meet the unique needs of these infants. But although researchers have suspected that microRNAs in breast milk have a role in infant health and development, no study has specifically looked at whether microRNAs differed between premature and term breast milk.
The researchers collected 36 samples of breast milk from mothers with infants born at term and 31 samples from mothers with infants born prematurely. Then they processed the samples in a lab, extracting the microRNAs and comparing them to the human genome to pinpoint the differences between premature and term breast milk.
After the analysis, the researchers identified nine microRNAs that were significantly different in the premature breast milk. They found that these microRNAs target metabolic processes and may help regulate gastrointestinal function and energy use in premature babies.
Steven Hicks, assistant professor of pediatrics in the Penn State College of Medicine, said the results may help explain why premature infants tend to do better when breast-fed by their mothers.
"We know that babies born prematurely have better health outcomes with breast milk than with formula, and our results may explain some of these health benefits associated with breast-feeding," Hicks said. "The unique microRNA profiles that we found in premature breast milk seem well suited to premature infants, because they target metabolic pathways that could spark catch-up growth."
For example, microRNAs found in premature breast milk block both ADRB3 and NR3C1 gene expression -- both of which negatively affect adipogenesis, or fat storage. Blocking these pathways could help boost fat production in premature babies that are having problems gaining weight.
Hicks said the results could have several applications, including matching babies with donated breast milk.
"For a variety of reasons, babies who are born preterm often rely on donated breast milk," Hicks said. "Oftentimes, that milk comes from a mother who gave birth at term, and has been breast-feeding for months. That milk may not be optimal for a 32-week premature infant who was born two days ago."
Hicks also said the findings could lead to opportunities to create better baby formula in the future.
"MicroRNAs are an epigenetic material that is made by our bodies and is not present in formula. So even though formula is made to mirror the nutritional components of breast milk -- carbohydrates, lipids and proteins -- it doesn't have any of these epigenetic factors," Hicks said. "It is possible to create microRNAs in a lab and put them in formula. This approach might help bridge the health gap we see between formula- and breast-fed infants."
The researchers said the study helps reinforce that breast milk has multiple nutritional benefits, and may be adapted to individual infant's needs.
This research was funded by the National Institutes for Health, the Center for Research on Women and Newborns (CROWN) Foundation, and the Pennsylvania Tobacco Cure Fund.
Related Microrna Articles:
An international team of researchers has discovered that a microRNA produced by certain white blood cells can prevent excessive inflammation in the intestine.
The molecule microRNA-210 stabilises deposits in the carotid artery and can prevent them from tearing.
Scientists partially re-insulated ravaged nerves in mouse models of multiple sclerosis (MS) and restored limb mobility by treating the animals with a small non-coding RNA called a microRNA.
Molecular biologists at UT Southwestern Medical Center were able to uncover a new mechanism that choreographs a complex molecular dance by applying the latest in gene editing technology combined with a traditional method of making a microRNA target produce a fluorescent green protein.
Chen-Yu Zhang's group at Nanjing University reports photo-clickable miRNAs as probes for intracellular target identification of miRNAs.
In this issue of JCI Insight, researchers led by Iris Jaffe of Tufts Medical Center provide evidence that age-related reductions of a microRNA (miR-155) underlie age-associated hypertension.
A study led by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, finds that a microRNA called let-7 plays a central role in curbing neuroblastoma and could focus efforts to find a targeted, nontoxic alternative to chemotherapy.
This review provides an overview of current therapeutic targets of miRNA-associated chemoresistance in EOC and illustrates the therapeutic potential and molecular mechanisms by which miRNAs influence the development and reversal of chemoresistance.
In a new study published online this week in The FASEB Journal, a Brigham and Women's Hospital research team investigated the role of miR-181b in blocking the development of arterial thrombosis.
By increasing the level of a specific microRNA (miRNA) molecule, researchers have for the first time restored chemotherapy sensitivity in vitro to a line of human pancreatic cancer cells that had developed resistance to a common treatment drug.
Related Microrna Reading:
MicroRNA Detection and Target Identification: Methods and Protocols (Methods in Molecular Biology)
by Tamas Dalmay (Editor)
This volume is a collection of miRNA detection and target identification protocols, detailing new developments in the traditional detection approaches such as northern blot, quantitative real-time PCR, array, next generation sequencing, and in situ hybridization. The chapters in MicroRNA Detection and Target Identification: Methods and Protocols guide readers through novel approaches such as nanotechnology, microfluidics, based detection methods, analysis of serum and urinary, miRNAs as biomarkers, target identification and experimental approaches. Written in the highly... View Details
microRNA: Cancer: From Molecular Biology to Clinical Practice (Advances in Experimental Medicine and Biology)
by Gaetano Santulli (Editor)
This volume thoroughly explores of the functional role of microRNAs in cancer. It not only expertly describes the molecular mechanisms underlying the malignant transformation process but also compiles cutting-edge research on microRNAs in several forms of cancer, including colorectal cancer, pancreatic cancer, leukemia/lymphoma, prostate cancer, lung cancer, ovarian cancer, and bone cancer. Distinguished experts, currently working in prestigious institutions, elegantly discuss these fundamental themes. The text, which opens with a foreword by the renowned Dr. Carlo M. Croce, is enhanced by... View Details
MicroRNA in Regenerative Medicine
by Chandan K. Sen (Editor)
This work encapsulates the uses of miRNA across stem cells, developmental biology, tissue injury and tissue regeneration. In particular contributors provide focused coverage of methodologies, intervention and tissue engineering.Regulating virtually all biological processes, the genome’s 1048 encoded microRNAs appear to hold considerable promise for the potential repair and regeneration of tissues and organs in future therapies. In this work, 50 experts address key topics of this fast-emerging field. Concisely summarizing and evaluating key findings emerging from fundamental... View Details
MicroRNAs: From Basic Science to Disease Biology
by Krishnarao Appasani (Editor), Sidney Altman (Editor), Victor R. Ambros (Editor)
MicroRNAs (miRNAs) are RNA molecules, conserved by evolution, that regulate gene expressions and their recent discovery is revolutionising both basic biomedical research and drug discovery. Expression levels of MiRNAs have been found to vary between tissues and with developmental stages and hence evaluation of the global expression of miRNAs potentially provides opportunities to identify regulatory points for many different biological processes. This wide-ranging reference work, written by leading experts from both academia and industry, will be an invaluable resource for all those wishing to... View Details
microRNA: Biology, Function & Expression (Nuts & Bolts series)
by Neil J. Clarke PhD (Author), Philippe Sanseau PhD (Author)
Providing a comprehensive overview of a fast-emerging field, this volume dedicated to the biological role of microRNAs (miRNAs) discusses methods for identifying and characterizing their functions and looks at potential applications of microRNA research in medicine and pharmacology. miRNAs are small, noncoding RNA molecules that appear to regulate gene expression. Found in plant and animal species and possibly traceable back to ancient forms of life, miRNAs are now estimated to regulate a third or more of genes in the human genome. The Editors have included material from some of the very... View Details
MicroRNAs and Other Non-Coding RNAs in Inflammation (Progress in Inflammation Research)
by Catherine M. Greene (Editor)
The book serves as a comprehensive resource for scientists and clinicians studying the role of non-coding RNAs in inflammation (viral infections, wound inflammation), human inflammatory diseases (i.e. rheumatoid arthritis, Crohn’s disease, diabetes) and innate immunity. It provides a universal reference work comprising both basic and specialized information. Given that ncRNAs represent new therapeutic targets, this volume will also be of interest to industrial biomedical researchers and those involved in drug development. View Details
Bioinformatics in MicroRNA Research (Methods in Molecular Biology)
by Jingshan Huang (Editor), Glen M. Borchert (Editor), Dejing Dou (Editor), Jun (Luke) Huan (Editor), Wenjun Lan (Editor), Ming Tan (Editor), Bin Wu (Editor)
This thorough volume provides an in-depth introduction to and discussion of microRNAs (miRs) and their targets, miR functions, and computational techniques applied in miR research, thus serving the need for a comprehensive book focusing on miR target genes, miR regulation mechanisms, miR functions performed in various human diseases, and miR databases/knowledgebases. Without prior knowledge of the area of study, computational biologists, computer scientists, bioinformaticians, bench biologists, as well as clinical investigators will find it easy to follow the techniques in this collection.... View Details
MicroRNA Interference Technologies
by Zhiguo Wang (Author)
MicroRNAs (miRNAs), endogenous noncoding regulatory mRNAs of around 22-nucleotides long, have rapidly emerged as one of the key governors of the gene expression regulatory program in cells of varying species, with ever-increasing implications in the control of the fundamental biological processes and in the pathogenesis of adult humans. The exciting findings in this field have inspired us with a premise and a promise that miRNAs will ultimately be taken to the heart for therapy of human disease. While miRNAs have been considered potential therapeutic targets for disease treatment, it... View Details
Translating MicroRNAs to the Clinic
by Academic Press
Translating microRNA to the Clinic reviews the possibilities of current methodological tools and experimental approaches used by leading translational researchers. The book features the uses of micro ribonucleic acid as deployed in cancer targeting in biomarkers, diabetes, cardiovascular disease, and neurodegeneration, among many others.
Pedagogically, the work concentrates on the latest knowledge, laboratory techniques, and experimental approaches used by translational research leaders in this field, promoting a cross-disciplinary communication between the sub-specialities... View Details
MicroRNAs in Medicine
by Charles H. Lawrie (Editor)
MicroRNAs in Medicine provides an access point into the current literature on microRNA for both scientists and clinicians, with an up-to-date look at what is happening in the emerging field of microRNAs and their relevance to medicine. Each chapter is a comprehensive review, with descriptions of the latest microRNA research written by international leaders in their field. Opening with an introduction to what microRNAs are and how they function, the book goes on to explore the role of microRNAs in normal physiological functions, infectious diseases, non-infectious diseases, cancer,... View Details